| pubmed-article:21135526 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21135526 | lifeskim:mentions | umls-concept:C1335951 | lld:lifeskim |
| pubmed-article:21135526 | lifeskim:mentions | umls-concept:C0030797 | lld:lifeskim |
| pubmed-article:21135526 | lifeskim:mentions | umls-concept:C0442034 | lld:lifeskim |
| pubmed-article:21135526 | lifeskim:mentions | umls-concept:C0079419 | lld:lifeskim |
| pubmed-article:21135526 | lifeskim:mentions | umls-concept:C0597879 | lld:lifeskim |
| pubmed-article:21135526 | lifeskim:mentions | umls-concept:C0443199 | lld:lifeskim |
| pubmed-article:21135526 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21135526 | pubmed:dateCreated | 2010-12-7 | lld:pubmed |
| pubmed-article:21135526 | pubmed:abstractText | Serous neoplasms of the female pelvis share a müllerian phenotype. Unlike low-grade serous neoplasms (LGSNs), high-grade serous carcinomas (HGSCs) commonly display p53 mutations. The current study correlates p53 immunoreactivity in peritoneal washings with the cytologic interpretation and histology of the corresponding serous neoplasm. | lld:pubmed |
| pubmed-article:21135526 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21135526 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21135526 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21135526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21135526 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21135526 | pubmed:issn | 0001-5547 | lld:pubmed |
| pubmed-article:21135526 | pubmed:author | pubmed-author:CrumChristoph... | lld:pubmed |
| pubmed-article:21135526 | pubmed:author | pubmed-author:CibasEdmund... | lld:pubmed |
| pubmed-article:21135526 | pubmed:author | pubmed-author:ChangMartin... | lld:pubmed |
| pubmed-article:21135526 | pubmed:author | pubmed-author:KindelbergerD... | lld:pubmed |
| pubmed-article:21135526 | pubmed:copyrightInfo | Copyright © 2010 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:21135526 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21135526 | pubmed:volume | 55 | lld:pubmed |
| pubmed-article:21135526 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21135526 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21135526 | pubmed:pagination | 79-84 | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:meshHeading | pubmed-meshheading:21135526... | lld:pubmed |
| pubmed-article:21135526 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21135526 | pubmed:articleTitle | High-grade and low-grade pelvic serous neoplasms demonstrate differential p53 immunoreactivity in peritoneal washings. | lld:pubmed |
| pubmed-article:21135526 | pubmed:affiliation | Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. | lld:pubmed |
| pubmed-article:21135526 | pubmed:publicationType | Journal Article | lld:pubmed |
